GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » EV-to-Revenue

Magle Chemoswed Holding AB (OSTO:MAGLE) EV-to-Revenue : 2.48 (As of May. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Magle Chemoswed Holding AB's enterprise value is kr424.4 Mil. Magle Chemoswed Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr171.1 Mil. Therefore, Magle Chemoswed Holding AB's EV-to-Revenue for today is 2.48.

The historical rank and industry rank for Magle Chemoswed Holding AB's EV-to-Revenue or its related term are showing as below:

OSTO:MAGLE' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.81   Med: 2.45   Max: 3.67
Current: 2.48

During the past 6 years, the highest EV-to-Revenue of Magle Chemoswed Holding AB was 3.67. The lowest was 1.81. And the median was 2.45.

OSTO:MAGLE's EV-to-Revenue is ranked better than
77.06% of 1042 companies
in the Biotechnology industry
Industry Median: 8.215 vs OSTO:MAGLE: 2.48

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Magle Chemoswed Holding AB's stock price is kr33.20. Magle Chemoswed Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr15.90. Therefore, Magle Chemoswed Holding AB's PS Ratio for today is 2.09.


Magle Chemoswed Holding AB EV-to-Revenue Historical Data

The historical data trend for Magle Chemoswed Holding AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB EV-to-Revenue Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - 3.50 2.69 2.26 1.91

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 2.41 2.51 1.91 2.42

Competitive Comparison of Magle Chemoswed Holding AB's EV-to-Revenue

For the Biotechnology subindustry, Magle Chemoswed Holding AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's EV-to-Revenue falls into.



Magle Chemoswed Holding AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Magle Chemoswed Holding AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=424.438/171.134
=2.48

Magle Chemoswed Holding AB's current Enterprise Value is kr424.4 Mil.
Magle Chemoswed Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr171.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB  (OSTO:MAGLE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Magle Chemoswed Holding AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=33.20/15.897
=2.09

Magle Chemoswed Holding AB's share price for today is kr33.20.
Magle Chemoswed Holding AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr15.90.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines